Despite numerous advancements in modern medicine, antimicrobial resistance (AMR) remains a global threat to healthcare systems worldwide. To address this problem, Antimicrobial Stewardship Programs (AMSPs) are crucial, with Diagnostic Stewardship (DS) emerging as a key element. DS involves the judicious use of diagnostic tests to improve patient outcomes and combat drug resistance. Implementing DS remains unclear but doesn’t hinder program adoption. DS is integral to modern patient care, guiding treatment decisions, optimizing diagnostics, and enhancing patient outcomes.

1   bioMérieux, Pfizer  and Docplexus cordially invite you to an interactive LIVE webinar on 28th September 2023, from 05:00 – 06:00 PM IST, on “From Multi-disciplinary Point of Views to Stewardship Driven Point of Care.”   In this session, our esteemed speakers Dr. Prithwijit Kundu, Prof. (Dr.) V. Balaji and Dr. Mrinal…